Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Mayo Clin Proc. 2013 Nov;88(11):10.1016/j.mayocp.2013.08.012. doi: 10.1016/j.mayocp.2013.08.012

Table 1.

Baseline characteristics of the study participants

Baseline Variables MCI (n=317) Normal cognition (n=1610) p-value
Male sex, N (%) 186 (58.7) 803 (49.9) 0.004
Age (years) -- median (IQR) 82.7 (79.2, 85.8) 79.7 (75.2, 83.6) <.001
Education (years) -- median (IQR) 12 (12, 15) 13 (12, 16) <.001
APOE E4 allele (E24/34/44 vs. 22/23/33), N (%)* 96 (30.7) 379 (23.9) 0.01
Hypertension, N (%) 254 (80.1) 1223 (76.0) 0.11
Stroke, N (%) 62 (19.6) 157 (9.8) <.001
BDI-II Depression (>13), N (%) ** 45 (15.0) 124 (8.0) 0.001
BMI, median (IQR)*** 26.9 (24.0, 29.8) 27.20 (24.4, 30.3) 0.04
Smokers, N (%) 0.90
Never 156 (49.2) 811 (50.4)
Current 15 (4.7) 69 (4.3)
Former 146 (46.1) 730 (45.3)
Coronary artery disease, N (%) 156 (49.2) 654 (40.6) 0.005
Diabetes Mellitus, N (%) 69 (21.8) 277 (17.2) 0.05
COPD, N (%) 78 (24.6) 210 (13.0) <.001

Notes: Data are n (%) or median (IQR). IQR = interquartile ratio; BMI = body mass index; BDI = Beck Depression Inventory; COPD = chronic obstructive pulmonary disease; MI = Myocardial infarction

*

25 patients missing APOE e4 status (21 Normal, 4 MCI).

**

75 patients missing BDI-II Depression (59 Normal, 16 MCI).

***

43 patients missing BMI (33 Normal, 10 MCI)

HHS Vulnerability Disclosure